🧬 @danielibrahim.bsky.social, moderated by @stefanschoenfelder.bsky.social, on enhancer-promoter specificity & how promoter-proximal regions act as molecular filters.
Register: us02web.zoom.us/webinar/regi...
March 5, 4PM UK.
#Genomics #GeneRegulation
📺 Now on YouTube: @dariloops.bsky.social on the evolution of 3D chromatin organization across metazoan species.
Part of our "The 3D Regulatory Genome" seminar series 🧬
🔗 www.youtube.com/watch?v=WoPA...
#Genomics #3DGenome #Epigenetics #Evolution
🧬 Our Chairman of the Board, Dietrich Stephan, discusses how 3D genome mapping is unlocking breakthrough therapies in Drug Discovery World's Winter issue.
We're deciphering causal biology behind genetic diseases & transforming drug discovery.
Read more: www.ddw-online.com/ddw-winter-2...
@enhancedgenomics.bsky.social announced the appointment of Dr Katerina Leftheris to its Board of Directors to support expansion of the Company’s therapeutics pipeline for complex and common genetic diseases.
Read more: tinyurl.com/2bb2dz75
🧬 Next seminar: @dariloops.bsky.social on how 3D chromatin organisation evolved across species—from CTCF-driven vertebrate TADs to chromatin-based invertebrate domains.
THURSDAY 12 FEBRUARY | 4PM UK | Zoom
Register: us02web.zoom.us/webinar/regi...
#Genomics #3DGenome #Evolution
🧬 Hiring: Bioinformatics Scientist at Enhanced Genomics, Cambridge UK
Profile 3D genome folding for drug discovery. Turn complex genomic data into therapeutic insights.
Apply: e3dg.bamboohr.com/careers/43
#bioinformatics #genomics #hiring
Our brand and website have undergone an exciting refresh!
enhancedgenomics.com
Using our 3D multi-omics platform and human cell type-specific atlas, we are the only biotech company able to define causal biology from disease-associated variants on a genome-wide scale.
Excited to pitch at Cambridge x London Life Sciences Showcase @ RESI JPM 2026 in San Francisco!
At Enhanced, we decipher human genetics to reveal drug targets others miss.
Join us during JPM Week to explore innovation: www.eventbrite.co.uk/e/cambridge-...
Join our virtual seminar!
@sedonamurphy.bsky.social presents cutting-edge research on 3D genome organisation & epigenetic memory in development, moderated by @stefanschoenfelder.bsky.social
📅 Jan 8, 4pm UK
💻 Zoom
Register: us02web.zoom.us/webinar/regi...
#3DGenome #Epigenetics #ChromatinBiology
@evgenykvon.bsky.social
@remeseiro-lab.bsky.social
@sj-marzi.bsky.social
@mosterwalder.bsky.social
@akispapantonis.bsky.social
@radaiglesiaslab.bsky.social
@andersshansen.bsky.social
@mariekeoudelaar.bsky.social
@axelvisel.bsky.social
@efapostolou29.bsky.social
@lucagiorgetti.bsky.social
🎄 Season's Greetings from Enhanced Genomics!
Thank you to our brilliant speakers and everyone who made 'The 3D Regulatory Genome' an outstanding 2025 seminar series. Your expertise has been inspiring.
Merry Christmas and Happy New Year! 🎁
Our 2026 line-up coming soon!
Excited to announce Enhanced will be at JPM Week 2026 (Jan 12-15) & pitching at the Cambridge x London Life Sciences Showcase on Jan 13th! 🧬
📍 RESI Conference, Marriott Marquis (12-4 PM)
Connect with Dietrich, @dnaturner.bsky.social & Kishen to discuss our genome-wide causal biology platform.
🧬 Our co-founder @stefanschoenfelder.bsky.social & John Skidmore just published in The Scientist on unlocking the "dark genome" for drug discovery. 95% of disease variants hide here—untapped potential for new therapeutics.
Read more: www.the-scientist.com/illuminating...
#Biotech
📢 Our Business Development Manager, Kishen is attending #investival!
Join him in London on Monday, 17 November, to explore new partnership opportunities.
Find out more: lnkd.in/eP7Cz4CS
#biotech #biopharma #medtech #healthtech
Thrilled to welcome Rachael Matthews to Enhanced Genomics! 🎉
Rachael brings expertise in epigenetics, CRISPR, and multi-omics from her PhD at Cambridge.
Joining Laura's team, she'll help us identify new targets for common diseases up to 10× faster. 🧬
Welcome, Rachael!
#Genomics #Biotech
Excited to be attending #BIOEurope!
Join our BD Manager, Kishen, in Vienna, Austria, November 3–5, 2025. Let’s make meaningful connections and drive innovation forward!
Register now: informaconnect.com/bioeurope/?u...
🧬Tomorrow at Bioinformatics & Drug Discovery Biology Strategy Meeting Europe 2025 (Crowne Plaza London Docklands): our Principal Scientist, Lyubomira, is sharing how we map disease-driving genes from GWAS variants 10× faster.
#Biotech #DrugDiscovery
🧬 New seminar alert! Dr. @axelvisel.bsky.social from @jgi.doe.gov joined us to discuss enhancer function and the regulatory genome.
🎥https://www.youtube.com/watch?v=jiSR4S7xdHI
#Genomics #CRISPR #Biotech
TOMORROW!
Register👉us02web.zoom.us/webinar/register/WN_do2h...
Our Chair Dietrich Stephan spoke with @genomeweb.bsky.social following the recent extension of our Series A funding, discussing our 3D multiomics platform and its potential to identify high-confidence targets for drug discovery and development.
Read more: www.genomeweb.com/business-new...
🧬Next speaker: @axelvisel.bsky.social (@berkeleylab.lbl.gov/@jgi.doe.gov) presents 'From Nucleotide
to Megabase Scale: Enhancer Function in Development and Disease'
👨🔬Moderated by @stefanschoenfelder.bsky.social
📅 Thu Oct 2, 4pm UK time
👉Register: us02web.zoom.us/webinar/regi...
#VirtualSeminar
We've extended our Series A to $19M to expand our therapeutic pipeline and scale through strategic partnerships.
Read more: enhancedgenomics.com/enhanced-gen...
@mariekeoudelaar.bsky.social
🧬@mariekeoudelaar.bsky.social joins @stefanschoenfelder.bsky.social in our next seminar "Molecular drivers of 3D genome folding and gene regulation"
🔬 Exploring enhancer-promoter interactions
🔬 Key proteins in chromatin dynamics
🔬 Impact on gene expression
Register: us02web.zoom.us/webinar/regi...
🧬 Our CSO @dnaturner.bsky.social presents at @agbt.bsky.social Precision Health (Sept 8-10, San Diego) on 3D genomics for personalized medicine.
🎯 Only company with genome-wide causal biology mapping—10× faster GWAS results.
👋 See you there!
#AGBTPH25 #3DGenomics
🧬 BREAKTHROUGH: Our partnership with ALBORADA Drug Discovery Institute (funded by Alzheimer's Research UK) used Enhanced Genomics' 3D multi-omics platform to identify novel therapeutic targets undetectable by conventional methods. 🤝
enhancedgenomics.com?p=2758&previ...
#Biotech #DrugDiscovery
🎉 We're thrilled to announce Dietrich Stephan as Chair of the Board! His deep genomics expertise joins us at a pivotal time as we accelerate our target identification pipeline for autoimmune diseases. Enhanced Genomics uniquely defines causal biology genome-wide! 🧬
🧬 Our CSO @dnaturner.bsky.social speaks at Cambridge Wide Open Week tomorrow (June 10th) at the 3:15PM session, The Glasshouse!
He'll present "Illuminating the Dark Genome" - how we use 3D multiomics to find new drug targets.
#Biotech #Cambridge #Innovation
📢 Next speaker in our '3D Regulatory Genome' series: Dr. Alvaro Rada Iglesias (@radaiglesiaslab.bsky.social) presenting innovative enhancer research using transgenic mouse stem cells!
Moderated by @stefanschoenfelder.bsky.social
Register: us02web.zoom.us/webinar/regi...
#Genomics #VirtualSeminar
